Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled α1‐protease inhibitor in cystic fibrosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Electrophoresis

• Publication date

  2001-01-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/1522-2683(200101)22:1<165::AID-ELPS165>3.0.CO;2-HPMID 11197168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 187. Degradation of surfactant protein A (SP-A) and other BAL proteins in patients with cystic fibrosis

  1999cited by this paper
• Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.

  1999cited by this paper
• Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.

  1999cited by this paper
• Proteomics in human disease: Cancer, heart and infectious diseases

  1999cited by this paper
• A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid.

  1998cited by this paper
• Proteolytic cleavage of ICAM-1 by human neutrophil elastase.

  1998cited by this paper
• Collectins and pulmonary host defense.

  1998cited by this paper
• Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.

  1998cited by this paper
• Pulmonary surfactant in cystic fibrosis.

  1997cited by this paper
• Melanie II – a third‐generation software package for analysis of two‐dimensional electrophoresis images: I. Features and user interface

  1997cited by this paper
• Cellular association of antiproteases in lavages from ventilated preterm human neonates.

  1997cited by this paper
• Lower airway inflammation in infants and young children with cystic fibrosis.

  1997cited by this paper
• Cystic fibrosis.

  1996cited by this paper
• Immunomodulatory Functions of Surfactant

  1995cited by this paper
• Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.

  1995cited by this paper
• Early pulmonary inflammation in infants with cystic fibrosis.

  1995cited by this paper
• The role of neutrophil elastase in chronic inflammation.

  1994cited by this paper
• Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.

  1994cited by this paper
• Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

  1994cited by this paper
• Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

  1991cited by this paper
• Aerosol α1 -antitrypsin treatment for cystic fibrosis

  1991cited by this paper
• Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract.

  1991cited by this paper
• Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

  1990cited by this paper
• Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.

  1989cited by this paper
• Two‐dimensional electrophoresis. The current state of two‐dimensional electrophoresis with immobilized pH gradients

  1988cited by this paper
• The current state of two-dimensional electrophoresis with immobilized pH gradients.

  1988cited by this paper
• Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels

  1987cited by this paper
• Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.

  1985cited by this paper
• Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

  1984cited by this paper

• Delivery of Alpha-1 Antitrypsin to Airways.

  2016cites this paper
• Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.

  2016cites this paper
• Identification of Critical Target Protein for Cystic Fibrosis using Systems Biology Network Approach

  2013cites this paper
• Annexins A1 and A2 as potential biomarkers of stress and respiratory disease susceptibility

  2013cites this paper
• Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties.

  2013cites this paper
• Inhaled Alpha 1-Antitrypsin: Gauging Patient Interest in a New Treatment

  2013cites this paper
• Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome

  2012cites this paper
• Lung protease/anti-protease network and modulation of mucus production and surfactant activity.

  2010cites this paper
• Comparative proteomic analysis of cancerous and adjacent normal lung tissues

  2010cites this paper
• Protein biomarkers in cystic fibrosis research: where next?

  2010cites this paper
• Protein biomarkers in cysticbrosis research: where next?

  2010cites this paper
• Lung deposition of inhaled Alpha-1-proteinase inhibitor (Alpha1-PI) - problems and experience of Alpha1-PI inhalation therapy in patients with hereditary Alpha1-PI deficiency and cystic fibrosis

  2010cites this paper
• Lung deposition of inhaled α1-proteinase inhibitor in CF and α1-antitrypsin deficiency

  2009cites this paper
• Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency

  2009cites this paper
• Proteomics of lung physiopathology

  2008cites this paper
• Inhibition of airway proteases in cystic fibrosis lung disease

  2008cites this paper
• Lung alveolar proteomics of bronchoalveolar lavage from a pulmonary alveolar proteinosis patient using high-resolution FTICR mass spectrometry

  2007cites this paper
• Role of Fas/FasL, inflammatory mediators and LPS-activated macrophages in human neutrophil apoptosis

  2007cites this paper
• Surfactant protein A and surfactant protein D variation in pulmonary disease.

  2007cites this paper
• Proteomics of bronchoalveolar lavage fluid and sputum

  2007cites this paper
• Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.

  2007cites this paper
• The Bronchoalveolar Lavage Proteome- Phenotypic associations to smoking and divergence towards development of COPD

  2006cites this paper
• Surfactant protein A--from genes to human lung diseases.

  2006cites this paper
• The matrix degrades, neutrophils invade

  2006cites this paper
• EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis

  2006cites this paper
• SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase

  2005cites this paper
• Antiinflammatory Therapies for Cystic Fibrosis: Past, Present, and Future

  2005cites this paper
• Differential Proteomic Analysis of Bronchoalveolar Lavage Fluid in Asthmatics following Segmental Antigen Challenge*S

  2005cites this paper
• Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.

  2005influential citation
• Optimum Peripheral Drug Deposition in Patients with Cystic Fibrosis

  2005cites this paper
• Proteomics of bronchoalveolar lavage fluid.

  2005cites this paper
• Interleukin-1, Neutrophil Elastase, and Lipopolysaccharide: Key Pro- Inflammatory Stimuli Regulating Inflammation in Cystic Fibrosis

  2005cites this paper
• Lungensurfactant bei cystischer Fibrose

  2004cites this paper
• High resolution mass spectrometric alveolar proteomics: Identification of surfactant protein SP‐A and SP‐D modifications in proteinosis and cystic fibrosis patients

  2004cites this paper
• Exploring the context of the lung proteome within the airway mucosa following allergen challenge.

  2004cites this paper
• Proteomics: current techniques and potential applications to lung disease.

  2004cites this paper
• Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease

  2004cites this paper
• Host Defense Functions of Pulmonary Surfactant

  2004cites this paper
• Proteomic analysis of lung biopsies: Differential protein expression profile between peritumoral and tumoral tissue

  2004cites this paper
• Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

  2004cites this paper
• Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.

  2003cites this paper
• Proteolysis of Surfactant Protein D by Cystic Fibrosis Relevant Proteases

  2003cites this paper
• Limited proteolysis of surfactant protein D causes a loss of its calcium-dependent lectin functions.

  2003cites this paper
• Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D.

  2002cites this paper
• Proteomics as the Tool to Search for Lung Disease Markers in Bronchoalveolar Lavage

  2002cites this paper
• Bronchoalveoläre Lavage bei Kindern mit malignen Erkrankungen, Immunsuppression, Fieber und Lungeninfiltraten

  2002influential citation
• Proteolytische Degradation von Surfactant Protein D

  2002cites this paper
• Protein pattern of exhaled breath condensate and saliva

  2002cites this paper
• Database of bronchoalveolar lavage fluid proteins.

  2002cites this paper
• Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex1

  2002cites this paper
• Bronchoalveolar lavage protein patterns in children with malignancies, immunosuppression, fever and pulmonary infiltrates

  2002cites this paper
• Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity.

  2001cites this paper
• Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.

  2001cites this paper
• Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis.

  2001cites this paper